[1]
K. Cuba Pérez and M. Condorhuamán Figueroa, “Use of tocilizumab in patients with SARS-CoV-2 at Hospital Nacional Dos de Mayo – Lima, 2020”, Ciencia e investigación, vol. 25, no. 1, pp. 29–34, Aug. 2022, doi: 10.15381/ci.v25i1.23472.